Hoth Therapeutics Files 8-K
Ticker: HOTH · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financial-statements
TL;DR
Hoth Therapeutics filed an 8-K, likely routine updates for the SEC.
AI Summary
Hoth Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting on other events and financial statements. The filing does not contain specific details about new material events or financial figures within the provided text.
Why It Matters
This filing indicates Hoth Therapeutics is providing updates to the SEC, which could contain important information for investors regarding the company's status or operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting events and financial statements, with no immediate indication of significant negative developments.
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- June 9, 2025 (date) — Date of Report
- Nevada (jurisdiction) — State of Incorporation
- 1177 Avenue of the Americas (address) — Principal Executive Offices
- New York, NY 10036 (address) — Principal Executive Offices
- (646) 756-2997 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing by Hoth Therapeutics, Inc.?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of June 9, 2025.
When was this 8-K filing submitted?
The filing was submitted on June 9, 2025.
In which state is Hoth Therapeutics, Inc. incorporated?
Hoth Therapeutics, Inc. is incorporated in Nevada.
What is the principal executive office address for Hoth Therapeutics, Inc.?
The principal executive office is located at 1177 Avenue of the Americas, 5th Floor, Suite 066, New York, NY 10036.
What is the telephone number listed for Hoth Therapeutics, Inc.?
The registrant's telephone number is (646) 756-2997.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Hoth Therapeutics, Inc. (HOTH).